Eton Pharmaceuticals, Inc. Interest Payable, Current
Eton Pharmaceuticals, Inc. (ETON) had Interest Payable, Current of $408.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2024-11-12
- 2024-09-30: Interest Payable, Current $408.00K.
- 2024-06-30: Interest Payable, Current $382.00K.
- 2024-03-31: Interest Payable, Current $354.00K.
- 2023-12-31: Interest Payable, Current $332.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2024-09-30 | $408.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $382.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $354.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $332.00K 10-Q · filed 2024-11-12 |
| 2023-09-30 | $307.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $281.00K 10-Q · filed 2023-08-10 |
| 2022-09-30 | $191.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $156.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $129.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |